20.33 USD
-1.04 (-4.87%)
20.33 USD
0 (0%)
Taking everything into account, SMLR scores 4 out of 10 in our fundamental rating. SMLR was compared to 185 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SMLR while its profitability can be described as average. SMLR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- In the past year SMLR was profitable.
- In the past year SMLR has reported a negative cash flow from operations.
- In the past 5 years SMLR has always been profitable.
- In the past 5 years SMLR always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of SMLR (8.10%) is better than 89.19% of its industry peers.
- SMLR has a Return On Equity of 10.51%. This is amongst the best in the industry. SMLR outperforms 87.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| ROIC | N/A |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- SMLR has a better Profit Margin (130.80%) than 99.46% of its industry peers.
- In the last couple of years the Profit Margin of SMLR has grown nicely.
- In the last couple of years the Operating Margin of SMLR has grown nicely.
- With an excellent Gross Margin value of 90.83%, SMLR belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
- In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 130.8% | ||
| GM | 90.83% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
- SMLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for SMLR has been increased compared to 1 year ago.
- Compared to 5 years ago, SMLR has more shares outstanding
- There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- Based on the Altman-Z score of 1.72, we must say that SMLR is in the distress zone and has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of 1.72, SMLR is in line with its industry, outperforming 55.68% of the companies in the same industry.
- A Debt/Equity ratio of 0.25 indicates that SMLR is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.25, SMLR is in line with its industry, outperforming 54.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.72 |
ROIC/WACCN/A
WACC9.93%
2.3 Liquidity
- SMLR has a Current Ratio of 1.97. This is a normal value and indicates that SMLR is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.97, SMLR is not doing good in the industry: 61.62% of the companies in the same industry are doing better.
- A Quick Ratio of 1.95 indicates that SMLR should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.95, SMLR is in line with its industry, outperforming 54.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.95 |
3. Growth
3.1 Past
- SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 220.88%, which is quite impressive.
- The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
- SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.30%.
- Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
3.2 Future
- The Earnings Per Share is expected to decrease by -29.01% on average over the next years. This is quite bad
- Based on estimates for the next years, SMLR will show a very negative growth in Revenue. The Revenue will decrease by -16.29% on average per year.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 2.32, the valuation of SMLR can be described as very cheap.
- Based on the Price/Earnings ratio, SMLR is valued cheaper than 100.00% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.47, SMLR is valued rather cheaply.
- SMLR is valuated quite expensively with a Price/Forward Earnings ratio of 249.14.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of SMLR indicates a somewhat cheap valuation: SMLR is cheaper than 65.41% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. SMLR is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.32 | ||
| Fwd PE | 249.14 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- The decent profitability rating of SMLR may justify a higher PE ratio.
- A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
5. Dividend
5.1 Amount
- No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
20.33
-1.04 (-4.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)02-16 2026-02-16
Inst Owners65.81%
Inst Owner Change-0.12%
Ins Owners4.75%
Ins Owner Change0%
Market Cap308.20M
Revenue(TTM)36.96M
Net Income(TTM)48.34M
Analysts82.22
Price Target66.98 (229.46%)
Short Float %20.65%
Short Ratio4.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1964.05%
Min EPS beat(2)1930.07%
Max EPS beat(2)1998.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.59%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)-0.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)118.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 2.32 | ||
| Fwd PE | 249.14 | ||
| P/S | 8.34 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.67 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)8.76
EY43.09%
EPS(NY)0.08
Fwd EY0.4%
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS2.44
BVpS30.33
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)0.1
Graham Number77.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.1% | ||
| ROE | 10.51% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 130.8% | ||
| GM | 90.83% | ||
| FCFM | N/A |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score2
Asset Turnover0.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 55.77% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.97 | ||
| Quick Ratio | 1.95 | ||
| Altman-Z | 1.72 |
F-Score2
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-126.25%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-354.87%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-244.7%
OCF growth 3Y14.98%
OCF growth 5Y13.91%
SEMLER SCIENTIFIC INC / SMLR FAQ
What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?
ChartMill assigns a fundamental rating of 4 / 10 to SMLR.
Can you provide the valuation status for SEMLER SCIENTIFIC INC?
ChartMill assigns a valuation rating of 4 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.
How profitable is SEMLER SCIENTIFIC INC (SMLR) stock?
SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 6 / 10.
What is the financial health of SEMLER SCIENTIFIC INC (SMLR) stock?
The financial health rating of SEMLER SCIENTIFIC INC (SMLR) is 3 / 10.